A

ANTX

AN2 Therapeutics, Inc.

3.300

-0.070-2.08%
Pre Market: 3.380  +0.080  +2.42%07:00 04/08 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE3.300/3.370
TODAY RANGE3.220-3.430
VOL335
MARKET CAP118.61M
52 WEEK RANGE1.000-6.91
AVG VOL (3M)1.40M
% TURNOVER0.46%
TURNOVER0
P/E (TTM)-2.8348
% RANGE6.23%
EPS(TTM)-1.1641
P/E(FORWARD)-3.6264
P/B1.705
BVPS1.936
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP66.09M
SHARES OUTSTANDING35.94M
NEXT EARNINGS05/01-05/15
FREE FLOAT20.03M
LOT SIZE1
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

ANTX

--

R

Regeneron Pharmaceuticals

REGN

-1.98%
761.85

G

GridAI Tech

GRDX

-8.79%
2.180

BNTX

--

U

United Therapeutics Corp.

UTHR

-0.96%
564.81

VRTX

--

S

Siga Technologie

SIGA

+1.35%
5.24

M

Moderna

MRNA

+0.69%
49.11

C

Charles Riv Labs Intl Inc

CRL

-0.58%
173.89

M

Medpace Holdings

MEDP

+1.81%
498.34

TLPH

--

ICLR

--

C

China Biologic

CBPO

0.00%
119.99

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

-3.87%
3.850

A

Arcturus Therape

ARCT

+2.29%
8.03

G

Gilead Sciences Inc

GILD

-0.42%
139.71

P

PRA Health

PRAH

0.00%
165.21

I

Incyte Corp

INCY

+1.73%
95.93

A

Aptevo Therapeutics Inc

APVO

0.00%
4.170

B

Biospecifics

BSTC

0.00%
88.53